Chinese medtech startup SiBionics has raised nearly 500 million yuan ($71.7 million) in a Series D round of financing to expand its development of AI-based medical devices for chronic disease management.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
